Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02602392 · ClinicalTrials.gov registry record · Phase 2
Online Asthma Self-Management for Children Aged 5-10 and Their Parents
A Phase 2 study of Asthma, sponsored by Oregon Center for Applied Science.
- Completed
- Registry status
- Phase 2
- Development phase
- 622
- Enrollment target
- 1
- Study location
NCT02602392: Completed Phase 2 study of Asthma, sponsored by Oregon Center for Applied Science.
NCT02602392 is a Phase 2 study of Asthma that has completed, run by Oregon Center for Applied Science. The registered enrollment target is 622 participants, below the 1,562-participant average among 374 other Asthma trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02602392, a Phase 2 study of Asthma, has completed, sponsored by Oregon Center for Applied Science.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 622 participants
- Enrollment target
- 1
- Study location
Study Summary
The potential benefits of this research to public health include improved understanding of cultural factors in pediatric asthma self-management, improved self-management skills for children, and better asthma management skills for their parents. This could result in eased suffering and improved quality of life for millions of children and their families, and also reduce the economic burden borne by society in the forms of medical expenditures and lost productivity.
Primary Outcome
A 5-item knowledge scale was developed with program-specific questions regarding asthma physiology, response to worsening symptoms, and asthma medications. These items used a 3-response choice scheme: "true," "not true," and "I don't know." The total number of items correct was summed to form the knowledge scale.
Conditions Studied
Interventions
- BEHAVIORAL Lungtropolis
- BEHAVIORAL Asthma educational booklet
Study Locations (1)
Oregon
- Oregon Center for Applied Science - Eugene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 622 participants |
| Start Date | 2011-01 |
| Est. Completion | 2011-09 |
| Phase | Phase 2 |
What the finished NCT02602392 record still lists
NCT02602392 is an interventional study that assigns participants to a tested intervention. The registered 622 participants enrollment target is mid-sized for trials with a published cap, below the 1,562-participant average among 374 other Asthma trials with a reported enrollment target (60% lower).
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 2 interventions - of which Lungtropolis is the first listed.
NCT02602392 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT02602392 about?
NCT02602392 is a clinical study titled "Online Asthma Self-Management for Children Aged 5-10 and Their Parents". The potential benefits of this research to public health include improved understanding of cultural factors in pediatric asthma self-management, improved self-management skills for children, and better asthma management skills for their parents. This could result in eased suffering and improved qual...
What is the current status of trial NCT02602392?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 622 participants. The study started on 2011-01. Estimated completion is 2011-09.
What conditions does trial NCT02602392 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT02602392?
The interventions under investigation include: Lungtropolis (BEHAVIORAL), Asthma educational booklet (BEHAVIORAL).
Who is sponsoring clinical trial NCT02602392?
This trial is sponsored by Oregon Center for Applied Science, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02602392 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02602392's enrollment target sits among peer trials
622 66th of 374 higher than 309 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Metformin IN Asthma for Overweight and Obese Individuals (MINA)
RECRUITING · Phase 2
-
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
RECRUITING · Phase 2
-
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
RECRUITING · Phase 2
-
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
RECRUITING · Phase 2
-
Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06712355 · 621 participants · Phase 3
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
- NCT06406049 · 624 participants · NA
Finishing HIV Project
- NCT02282969 · 620 participants
PCORI-CER-1306-03385 Lung Cancer Screening Decision Aid Development and Testing
- NCT02838836 · 620 participants
Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia